{"id":109648,"date":"2024-10-23T17:00:02","date_gmt":"2024-10-23T14:00:02","guid":{"rendered":"https:\/\/www.sfee.gr\/?p=109648"},"modified":"2024-10-25T11:51:24","modified_gmt":"2024-10-25T08:51:24","slug":"greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access","status":"publish","type":"post","link":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/","title":{"rendered":"Greek hospital drug funding crisis, pharma sector warns on patient access"},"content":{"rendered":"
\n
\n
Statement<\/a>\u00a0by Michael Himonas, General Manager of SFEE, at Euractiv.com<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
The pharmaceutical industry has highlighted the need for an urgent revision of Greek public hospitals\u2019 pharmaceutical budget. Clawbacks reached an all-time high for the first half of 2023, raising concerns about ongoing patients\u2019 access<\/div>\n
\n
\n
\n
\n

\u201cCurrently, we have observed that only 1 in 5 new medicines are available in Greece.\u201d<\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
Vasiliki Angouridi<\/a><\/span>\u00a0Euractiv<\/a><\/span>\u00a0\u00a023-10-2024<\/span><\/span>\u00a0\u00a022:15<\/span>\u00a0\u00a0<\/span><\/div>\n<\/div>\n
\n

 <\/p>\n

The pharmaceutical industry has highlighted the need for an urgent revision of Greek public hospitals\u2019 pharmaceutical budget. Clawbacks reached an all-time high for the first half of 2023, raising concerns about ongoing patients\u2019 access.<\/strong><\/p>\n

A\u00a0broad definition of \u201cclawback\u201d<\/a>\u00a0refers to \u201cthe amount pharmaceutical companies have to return to the state when public spending on drugs exceeds the budget.\u201d It is an added measure to mandatory rebates and other discounts, initially introduced in Greece in 2012 during the financial crisis.<\/p>\n

At first, it involved only the public pharmaceutical outpatient expenditure, but 2016 marked the year the policy was introduced to the state pharmaceutical expenditure of the national health system\u2019s hospitals.<\/p>\n

Since then, the state pharmaceutical budget has remained more or less stagnant, while expenditures have increased following the growing needs of an ageing population and advances in medicines.<\/p>\n

\u201cThe major problem remains the underfunding of pharmaceutical expenditure, a consequence of the MoUs imposed during the crisis (2010-2018),\u201d Mihalis Himonas, General Manager of SFEE, the Hellenic Association of Pharmaceutical Companies, told Euractiv.<\/p>\n

\u201cEven though we have exited this era, the gap in pharmaceutical funding continues to widen. Currently, we have observed that only 1 in 5 new medicines are available in Greece (IQVIA study 2024 covering the four-year period 2020 \u2013 2023), with our country\u00a0maintaining the highest pharmaceutical industry returns in the EU,\u201d he added.<\/p>\n

 <\/p>\n

Industry in shock<\/strong><\/h2>\n

Government notes on the clawback amount the companies must return for the first half of 2023 arrived this October following a 16-month delay. According to those notes, the mandatory returns for the largest portion of the market reached 83% (for products priced above \u20ac30), while at one hospital, Papageorgiou in Thessaloniki, they reached 92%.<\/p>\n

\u201cThe recent release of the hospital clawback notes for the first half of the year 2023 spread great disappointment in the pharmaceutical market\u201d, Himonas commented.<\/p>\n

The reaction of the associations representing the pharmaceutical companies was immediate, with press releases, while SFEE sent a letter to the Prime Minister, Kyriakos Mitsotakis, expressing concerns. The Board of Directors asked for an immediate revision of the pharmaceutical budget in hospitals.<\/p>\n

\u201cThe unprecedented returns for hospital medicines by European and global standards indicate the consistently failed pharma policy and extreme underfunding of the hospital pharmaceutical budget. It is evident that a \u2018wrong\u2019 restricted budget, even within public hospitals, can have detrimental effects on both the pharmaceutical companies and the patients relying on these medicines,\u201d the letter said.<\/p>\n

Medicines in Greece are priced at the average of the two lowest prices in the Eurozone.<\/p>\n

 <\/p>\n

Minimal improvement<\/strong><\/h2>\n

The industry outcry was followed by a meeting last week with the Minister of Health, Adonis Georgiadis, and all four associations (SFEE, Pharma Innovation Forum, the Panhellenic Pharmaceutical Industry Association, and SAFEE). Georgiadis was joined by the Deputy Minister to the Prime Minister, Thanasis Kontogeorgis.<\/p>\n

\u201cIt is unfortunate that in October 2024, there is a significant challenge in adjusting state expenditure for the previous year,\u201d Himonas said to Euractiv.<\/p>\n

\u201cThis was evident in the recent meeting with the Minister of Health, where we were informed of an additional funding of only \u20ac20 million, combined with internal reallocations of clawback and additions to the expenditure from closed budget residues. No one should expect the pharmaceutical sector to be sustainable with returns of approximately 76% (instead of 82.9%)!\u201d he added.<\/p>\n

At the meeting, Georgiadis announced some corrective actions, including emergency funding of \u20ac20 million from the Ministry of Finance. Also, \u20ac33 million is expected to be transferred from unspent funds from closed budgets. With a change of discount rates on clawback, the clawback on products over 30\u20ac will be reduced by \u20ac20 million.<\/p>\n

 <\/p>\n

Extreme unsustainability\u00a0<\/strong><\/h2>\n

In an announcement following the meeting, SFEE talked about \u201cminimal improvement in funding for hospital medicines\u201d, adding that \u201cthe State funds 2.4 medicines out of 10, while the pharmaceutical industry funds the remaining 7.6.\u201d<\/p>\n

\u201cWe appreciate the efforts of the Ministry of Health to address the issues in hospitals, noting that it is the first channel that has reached a point of extreme unsustainability, and we stand by his commitments that returns for hospital medicines in 2024 will be lower than those in 2022, which were also extremely high (69%) and must be significantly reduced in the coming years. We also value the efforts to reduce spending and increase the return on investment in medicine,\u201d Himonas underscored.<\/p>\n

However, he added that the serious problem of underfunded pharmaceutical expenditure, the legacy of the MoUs, remains, while significant barriers to patients\u2019 access to new medicines in Greece persist, as the\u00a0IQVIA study<\/a>\u00a0showed.<\/p>\n

\u201cTo be fair to the current Minister of Health, he is trying to control prescriptions while increasing the efficiency of pharmaceutical investments. However, this is not enough to close the huge funding gap,\u201d Himonas added.<\/p>\n

The notes for the second semester of 2023 are expected before the end of November. They will include changes that have resulted from the aforementioned government interventions.<\/p>\n

\u201c situation calls into question patients\u2019 access to existing as well as new innovative therapies, acknowledging that medicine represents only 15% of the total health expenditure across Europe, which makes it necessary for the State to redefine its priorities,\u201d SFEE\u2019s announcement stated.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Statement by Michael Himonas, General Manager of SFEE at Euractiv.com<\/p>\n","protected":false},"author":12,"featured_media":104778,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[429,701],"tags":[],"class_list":["post-109648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-articles-interviews-speeches-en","entry"],"acf":[],"yoast_head":"\nGreek hospital drug funding crisis, pharma sector warns on patient access | SFEE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greek hospital drug funding crisis, pharma sector warns on patient access | SFEE\" \/>\n<meta property=\"og:description\" content=\"Statement by Michael Himonas, General Manager of SFEE at Euractiv.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\" \/>\n<meta property=\"og:site_name\" content=\"SFEE\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/sfeegreece\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-23T14:00:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T08:51:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1058\" \/>\n\t<meta property=\"og:image:height\" content=\"595\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/><meta property=\"og:image\" content=\"https:\/\/www.sfee.gr\/preview.jpg\" \/>\n<meta name=\"author\" content=\"zoe.magklara\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sfeegreece\" \/>\n<meta name=\"twitter:site\" content=\"@sfeegreece\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"zoe.magklara\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\"},\"author\":{\"name\":\"zoe.magklara\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207\"},\"headline\":\"Greek hospital drug funding crisis, pharma sector warns on patient access\",\"datePublished\":\"2024-10-23T14:00:02+00:00\",\"dateModified\":\"2024-10-25T08:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\"},\"wordCount\":909,\"image\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg\",\"articleSection\":[\"News\",\"Articles-Interviews-Speeches\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\",\"url\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\",\"name\":\"Greek hospital drug funding crisis, pharma sector warns on patient access | SFEE\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg\",\"datePublished\":\"2024-10-23T14:00:02+00:00\",\"dateModified\":\"2024-10-25T08:51:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage\",\"url\":\"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg\",\"contentUrl\":\"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg\",\"width\":1058,\"height\":595},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae\",\"item\":\"https:\/\/www.sfee.gr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Greek hospital drug funding crisis, pharma sector warns on patient access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#website\",\"url\":\"https:\/\/www.sfee.gr\/en\/\",\"name\":\"\u03a3\u03a6\u0395\u0395\",\"description\":\"The Hellenic Association of Pharmaceutical Companies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sfee.gr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207\",\"name\":\"zoe.magklara\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d3e3a69f11e65abbdd8cc9708e38f3baae0a6b22516a021ea9557fa235bfb247?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d3e3a69f11e65abbdd8cc9708e38f3baae0a6b22516a021ea9557fa235bfb247?s=96&d=mm&r=g\",\"caption\":\"zoe.magklara\"},\"url\":\"https:\/\/www.sfee.gr\/en\/author\/zoe-magklara\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Greek hospital drug funding crisis, pharma sector warns on patient access | SFEE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/","og_locale":"en_US","og_type":"article","og_title":"Greek hospital drug funding crisis, pharma sector warns on patient access | SFEE","og_description":"Statement by Michael Himonas, General Manager of SFEE at Euractiv.com","og_url":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/","og_site_name":"SFEE","article_publisher":"https:\/\/www.facebook.com\/sfeegreece\/","article_published_time":"2024-10-23T14:00:02+00:00","article_modified_time":"2024-10-25T08:51:24+00:00","og_image":[{"width":1058,"height":595,"url":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg","type":"image\/jpeg"},{"url":"https:\/\/www.sfee.gr\/preview.jpg","type":"","width":"","height":""}],"author":"zoe.magklara","twitter_card":"summary_large_image","twitter_creator":"@sfeegreece","twitter_site":"@sfeegreece","twitter_misc":{"Written by":"zoe.magklara","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#article","isPartOf":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/"},"author":{"name":"zoe.magklara","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207"},"headline":"Greek hospital drug funding crisis, pharma sector warns on patient access","datePublished":"2024-10-23T14:00:02+00:00","dateModified":"2024-10-25T08:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/"},"wordCount":909,"image":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg","articleSection":["News","Articles-Interviews-Speeches"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/","url":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/","name":"Greek hospital drug funding crisis, pharma sector warns on patient access | SFEE","isPartOf":{"@id":"https:\/\/www.sfee.gr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage"},"image":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg","datePublished":"2024-10-23T14:00:02+00:00","dateModified":"2024-10-25T08:51:24+00:00","author":{"@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207"},"breadcrumb":{"@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#primaryimage","url":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg","contentUrl":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2023\/02\/Article_feature_img_Himonas10.jpg","width":1058,"height":595},{"@type":"BreadcrumbList","@id":"https:\/\/www.sfee.gr\/en\/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae","item":"https:\/\/www.sfee.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Greek hospital drug funding crisis, pharma sector warns on patient access"}]},{"@type":"WebSite","@id":"https:\/\/www.sfee.gr\/en\/#website","url":"https:\/\/www.sfee.gr\/en\/","name":"\u03a3\u03a6\u0395\u0395","description":"The Hellenic Association of Pharmaceutical Companies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sfee.gr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/8753cc116d582dae972d12040b60c207","name":"zoe.magklara","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d3e3a69f11e65abbdd8cc9708e38f3baae0a6b22516a021ea9557fa235bfb247?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d3e3a69f11e65abbdd8cc9708e38f3baae0a6b22516a021ea9557fa235bfb247?s=96&d=mm&r=g","caption":"zoe.magklara"},"url":"https:\/\/www.sfee.gr\/en\/author\/zoe-magklara\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts\/109648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/comments?post=109648"}],"version-history":[{"count":1,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts\/109648\/revisions"}],"predecessor-version":[{"id":109649,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts\/109648\/revisions\/109649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/media\/104778"}],"wp:attachment":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/media?parent=109648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/categories?post=109648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/tags?post=109648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}